数字农科院2.0

Identification of Escherichia coli 166 isolate as an effective inhibitor of African swine fever virus replication

文献类型： 外文期刊

作者： Zhang, Jinya;Cui, Hongyu;Zhang, Zhenjiang;Wang, Wenqing;Jiang, Fengwei;Sun, Encheng;Zhu, Yuanmao;Li, Fang;Bu, Zhigao;Zhao, Dongming

作者机构：

关键词： African swine fever virus;Escherichia coli 166;wild boar;antiviral;NF-kappa B;CD163

期刊名称： MICROBIOLOGY SPECTRUM

ISSN：

年卷期： 2025 年

页码：

收录情况： SCIE（2025版）

摘要： African swine fever is a lethal disease with mortality rates approaching 100% in both domestic pigs and wild boars. With no effective vaccines or treatments available, there is an urgent need for new biologics to combat the African swine fever virus (ASFV). In this study, we isolated bacteria from the intestinal contents of wild boar using culture-based methods and identified them through 16S ribosomal DNA (rDNA) sequencing. These isolates underwent high-throughput screening to evaluate their immunomodulatory effects on J774-Dual cells and their ability to inhibit ASFV replication in vitro. Among them, an Escherichia coli strain, designated as E. coli 166, exhibited strong inhibitory effects on various ASFV strains' replication, including three genotype II strains: virulent strain HLJ/18, moderately virulent strain HLJ/HRB1/20, genetically modified low-virulent strain HLJ/18-6GD, and one genotype I low-virulent strain SD/DY-I/21. Notably, this inhibition did not require direct interaction between the bacteria and porcine alveolar macrophages (PAMs). Both live and heat-inactivated E. coli 166 demonstrated a strong inhibitory effect on ASFV replication. Genetic modification of E. coli 166 did not alter its inhibitory phenotype. Further analysis revealed that PAMs pretreated with E. coli 166 showed upregulation of NF-kappa B and downregulation of CD163 at different time points post-infection, whereas PAMs only infected with ASFV exhibited the opposite trend. These findings suggest that E. coli 166 holds promise as a biological agent for controlling ASFV infection, through indirect mechanisms involving bacterial metabolites or lysis products. Future studies should focus on identifying the specific components responsible for its antiviral effects. IMPORTANCE The emergence of the African swine fever virus (ASFV) as a devastating pathogen in swine populations necessitates the development of novel strategies for its control. In this study, Escherichia coli strain 166 (E. coli 166) demonstrated a remarkable ability to inhibit the replication of multiple ASFV strains in porcine alveolar macrophages (PAMs), even without direct bacterial contact. Both live and heat-inactivated E. coli 166 retained this inhibitory effect, suggesting that secreted metabolites or lysis products may play a key role. Furthermore, pretreatment of PAMs with E. coli 166 resulted in upregula ted NF-kappa B activity and downregulated expression of the ASFV entry receptor CD163, presenting an immune-modulatory mechanism distinct from PAMs solely infected with ASFV. These findings highlight the potential of E. coli 166 as a biological agent to combat ASFV, offering a promising alternative or complementary approach to traditional antiviral strategies.

分类号：

  • 相关文献

[1]The H240R Protein of African Swine Fever Virus Inhibits Interleukin 1 beta Production by Inhibiting NEMO Expression and NLRP3 Oligomerization. Zhou, Pingping,Dai, Jingwen,Zhang, Kehui,Wang, Tao,Li, Lian-Feng,Luo, Yuzi,Sun, Yuan,Qiu, Hua-Ji,Li, Su. 2022

[2]Serological surveillance for rabies and canine distemper in wild boar in Heilongjiang province, China. Wang H.,Guo H.,Wang L.,Yu S.,Li Y.,Wang X.. 2023

[3]First report of Echinococcus granulosus genotype 1 in a wild boar (Sus scrofa) from China. Baoping Guo,Cairen,Li Zhao,Kalibixiati Aimulajiang,Wenqiang Tang,Chuanchuan Wu,Maiweilidan Yimingjiang,Jianyong Wu,Rongsheng Mi,Hao Wen. 2024

[4]Influence of N-linked glycosylation of minor proteins of porcine reproductive and respiratory syndrome virus on infectious virus recovery and receptor interaction. Wei, Zuzhang,Tian, Debin,Sun, Lichang,Lin, Tao,Gao, Fei,Liu, Runxia,Tong, Guangzhi,Yuan, Shishan.

[5]Glycosyl-phosphatidylinositol (GPI)-anchored membrane association of the porcine reproductive and respiratory syndrome virus GP4 glycoprotein and its co-localization with CD163 in lipid rafts. Du, Yijun,Song, Cheng,Yoo, Dongwan,Li, Gang,Du, Yijun,Pattnaik, Asit K.,Pattnaik, Asit K.,Li, Gang.

[6]Pig macrophages with site-specific edited CD163 decrease the susceptibility to infection with porcine reproductive and respiratory syndrome virus. Kui XU,Yan rong ZHOU,Hai tao SHANG,Chang jiang XU,Ran TAO,Wan jun HAO,Sha sha LIU,Yu lian MU,Shao bo XIAO,Kui LI. 2023

[7]肿瘤坏死因子剪切酶在猪繁殖与呼吸综合征病毒感染中的作用. 郭龙军,王玉娥. 2014

[8]稳定表达猪繁殖与呼吸综合征病毒受体CD163的HEK293细胞系的建立. 牛军伟,郭龙军,谷伟红,黄明明,李忍,骆晓蕾,王玉娥. 2015

[9]猪繁殖与呼吸综合征病毒侵入介体的研究进展. 张奕强,刘文倩,刘永生,王印,张杰. 2011

[10]CD163双等位基因编辑猪的制备及传代. 魏迎辉,刘志国,徐奎,Evanna Huyhn,Paul Dyce,李继良,周伟良,董树仁,冯保亮,牟玉莲,Ju LangLi,李奎. 2018

[11]PRRSV细胞受体CD163 SYBR Green Ⅰ荧光定量RT-PCR方法的建立. 马小元,丁耀忠,王俊,张杰,张永光. 2017

[12]猪繁殖与呼吸综合征病毒感染相关受体的研究概况. 王凤雪,温永俊,武华. 2010

[13]CD163单等位基因表达的iPAMs细胞系的构建及其介导PRRSV感染的特征分析. 王慧,冯保亮,向光明,黄雷,刘志国,李奎,牟玉莲. 2023

[14]CD163基因在猪繁殖与呼吸综合征抗病育种中的研究进展. 王慧,冯保亮,吴丹,向光明,王楠,牟玉莲,李奎,刘志国. 2023

[15]猪繁殖与呼吸综合征抗病育种研究进展. 刘铃,王丹丹,崔凯,马月辉,蒋琳. 2022

[16]猪MSTN、pAPN和CD163基因同步编辑的胚胎制备. 谢浩,陈指龙,彭翠婷,潘颖婷,齐霖,赵玉兰,闭英连,宋子仪,唐中林. 2025

[17]Nitazoxanide inhibits the replication of Japanese encephalitis virus in cultured cells and in a mouse model. Shi, Zixue,Wei, Jianchao,Deng, Xufang,Qiu, Yafeng,Shao, Donghua,Li, Beibei,Zhang, Keyu,Xue, Feiqun,Ma, Zhiyong,Li, Shuqing,Wang, Xiaodu. 2014

[18]Lentivirus-mediated RNA interference against Japanese encephalitis virus infection in vitro and in vivo. Shen, Ting,Cao, Ruibing,Zhou, Bin,Chen, Puyan,Liu, Ke,Miao, Denian.

[19]CRISPR-Cas13d Exhibits Robust Antiviral Activity Against Seneca Valley Virus. Yu Yuan Zhang,Ming Xia Sun,Yuexiao Lian,Tong Yun Wang,Mei Yu Jia,Chaoliang Leng,Meng Chen,Yuan Zhe Bai,Fandan Meng,Xue Hui Cai,Yan Dong Tang. 2022

[20]Recombinant porcine Interferon-α and Interleukin-2 fusion protein (rPoIFNα+IL-2) shows potent anti-pseudorabies virus activity in vitro and in vivo. Kuan Zhao,Xiuli Li,Baishi Lei,Ying Han,Tongqing An,Wuchao Zhang,Huiwen Zhang,Bosen Li,Wanzhe Yuan. 2023

作者其他论文 更多>>